Angioplasty for symptomatic intracranial stenosis: Clinical outcome

Stroke

Volumn 37, Issue 4, 2006, Pages 1016-1020

  Marks, Michael P ^a   Wojak, Joan C ^b   Al Ali, Firas ^c   Jayaraman, Mahesh ^a   Marcellus, Mary L ^a   Connors, John J ^d   Do, Huy M ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b Our Lady of Lourdes Regional Medical Center   (United States)

^c BORGESS MEDICAL CENTER   (United States)

^d ST JOSEPH HOSPITAL   (United States)

Author keywords

Angioplasty; Arteriosclerosis; Basilar artery; Carotid arteries; Middle cerebral artery

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; HEPARIN; TICLOPIDINE; WARFARIN;

ADULT; AGED; ANGIOGRAPHY; ANGIOPLASTY; ARTICLE; BASILAR ARTERY; BRAIN ATHEROSCLEROSIS; CAROTID ARTERY OBSTRUCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STROKE; TRANSIENT ISCHEMIC ATTACK; BRAIN ANGIOGRAPHY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; FOLLOW UP; MIDDLE AGED; MULTICENTER STUDY; RADIOGRAPHY; STENOSIS, OCCLUSION AND OBSTRUCTION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR ACCIDENT; CONSTRICTION, PATHOLOGIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 33645813120     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000206142.03677.c2     Document Type: Article

References (20)

1. Sacco RI, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke. 1995;26:14-20.
2. Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke. 1996;27:1274-1980.
3. Bogousslavsky J, Barnett H, Fox A, Hachinski V, Taylor W. Atherosclerotic disease of the middle cerebral artery. Stroke. 1986;17:1112-1120.
4. Quereshi A, Suri M, Ziai W, Yahia A, Mohammad Y, Sen S. Stroke-free survival and its determinants in patients with symptomatic vertebrobasilar stenosis: a multicenter study. Neurosurgery. 2003;52:1033-1040.
5. Thijs VN, Albers GW. Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology. 2000;55:465-466.
6. Chimowitz ML, Lynn JM, Howlett-Smith H, Stern BJ, Heretzberg VS, Frandel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG. Warfarin-Aspiring Symptomatic Intracranial Disease Trial Investigators. N Engl J Med. 2005;352:1305-1316.
7. Chaturvedi S, Caplan LR. Angioplasty for intracranial atherosclerosis. Neurology. 2003;61:1647-1648.
8. Lynn M, Chimowitz M, Howlett-Smith H, Frankel M, et al. Warfarin versus aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Stroke. 2005;36:457.
9. Clark WM, Barnwell SL, Nesbit G, O'Neill OR, Wynn ML, Coull BM. Safety and efficacy of percutaneous transluminal angioplasty for intracranial atherosclerotic stenosis. Stroke. 1995;26:1200-1204.
10. Yokote H, Terada T, Ryujin K, Konoshita Y, Tsuura M, Nakai E, Kamei I, Moriwaki H, Hayashi S, Itakura T. Percutaneous transluminal angioplasty for intracranial arteriosclerotic lesions. Neuroradiology. 1998;40:590-596.
11. Marks MP, Marcellus ML, Norbash AM, Steinberg GK, Tong D, Albers GW. Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke. 1999;30:1065-1069.
12. Connors JJ, Wojak JC. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J Neurosurg. 1999;91:415-423.
13. Lee JH, Kwon SU, Lee JH, Suh DC, Kim JS. Percutaneous transluminal angioplasty for symptomatic middle cerebral artery stenosis: long term follow-up. Cerebrovasc Dis. 2003;15:90-97.
14. Marks MP, Marcellus ML, Do HM, Schraedley-Desmond PK, Steinberg GK, Tong DC, Albers GW. Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. Am J Neuroradiol. 2005;26:25-30.
15. Gupta R, Schumacher HC, Mangla S, Meyers PM, Duong H, Khandji AG, Marshall RS, Mohr JP, Pile-Spellman J. Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis. Neurology. 2003;61:1729-1735.
16. SSLYVIA Study Investigators. Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries. Stroke. 2004;35:1388-1392.
17. Kim DJ, Lee BH, Kim DI, Shim WH, Jeon P, Lee TH. Stent-assisted angioplasty of symptomatic intracranial vertebrobasilar artery stenosis: feasibility and follow-up results. AJNR. 2005;16:1381-1388.
18. Chow MM, Masaryk TJ, Woo HH, Mayberg MR, Rasmussen PA. Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: midterm analysis of clinical and radiologie predictors of neurological morbidity and mortality. AJNR. 2005;16:869-874.
19. JiangWJ, Wang YJ, Du B, Wang SX, Wang GH, Jin M, Dai JP. Stenting of symptomatic M1 stenosis of middle cerebral artery. An initial experience of 40 patients. Stroke. 2004;35:1375-1380.
20. Yu Q, Smith WS, Singh V, Ko NU, Cullen SP, Dowd CF, Halbach VV, Higashida RT. Long-term outcome of endovascular stenting for symptomatic basila artery stenosis. Neurology. 2005;64:11055-1057.